Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Unimark Remedies

Request full access

Healthcare company, developing affordable generic medicines in various therapeutic segments

Mumbai, IndiaFounded 1983Biotech & Life Sciences

About Unimark Remedies

In 1982, Unimark Remedies was founded, starting its journey as a marketing company. The playbook shifted in 1995 when the company integrated backwards into manufacturing Active Pharmaceutical Ingredients (APIs), the core components of medicines. This move set the stage for growth, and by 1997, Unimark acquired an antibiotic facility in Bavla, India. The company focused on developing and manufacturing generic drugs across therapeutic areas like respiratory and cardiovascular, aiming to be a global, integrated life sciences player. The mid-2000s marked a period of significant milestones, with its manufacturing plants in Vapi and Bavla receiving US FDA approval in 2006 and 2007, respectively. This opened the door for international expansion. In 2007, Citi Venture Capital invested Rs 113 crore for a 27% stake, valuing the company at Rs 380 crore. Another strategic investment came in 2011 from Hikma Pharmaceuticals, which acquired a minority stake for $33.3 million to gain access to Unimark's API manufacturing capabilities. However, the company's trajectory shifted. In 2018, after defaulting on a major loan, Unimark Remedies was admitted for corporate insolvency. The story took its final turn in April 2023, when a bankruptcy court approved an acquisition plan from a consortium including Intas Pharmaceuticals and Shamrock Pharmachemi for about Rs 250 crore. Today, Unimark Remedies is 100% owned and managed by the Shamrock Pharmagroup, closing one chapter and beginning another under new ownership.

Source: Dealroom company data

At a glance

Status
Operational
Employees
546
Open positions
None listed
Dealroom signal
35.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Cardiology and cardiovascular
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Apr 2011 $33M $133M Hikma Pharmaceuticals —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Unimark Remedies website traffic

Latest recorded traffic for Unimark Remedies is 10K monthly website visits, up 2602.7% over the last three months. Unimark Remedies's team grew 3.8% over the past year.

Latest monthly visits10K 3-month web change+2602.7% 1-year team growth+3.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Unimark Remedies in the Mumbai ecosystem

Live from Dealroom

The Unimark Remedies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Hikma Pharmaceuticals
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇮🇳 India96.1%
🇵🇰 Pakistan1%
🏳️ Afghanistan0.5%
🇦🇪 United Arab Emirates0.5%
🇳🇮 Nicaragua0.5%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Unimark Remedies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Unimark Remedies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.